Recent studies have reported that metabolic reprogramming in MYCN-amplified NB is dependent on the activation of one-carbon metabolism pathway, and MTHFD1 is identified as one of the significant DEGs in this pathway based on the sequencing results [20, 32, 33]. The gene discussed is MTHFD1; the disease is neuroblastoma.